Everything below concerns nitric oxide system. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Approximate, for sequence GEPPPGKPADDAGLV |
| Molecular mass | ~1419 Da | Neutral form |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Typical storage | -20 C | Dry powder, protected from moisture |
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
== Structure and stereochemistry == AMPT is related to tyrosine, an amino-acid component of proteins. It contains an extra methyl group in the α-position where tyrosine would have a hydrogen atom. This position is a stereocentre and in natural amino-acids takes the S absolute configuration. However, the alternative R form of AMPT is also known, as is the racemic material which contains equal amounts of the R and S isomers. The S isomer has been developed as the drug metirosine and, as with many chiral drugs, the racemate was also of interest as a potentially cheaper material, known as racemetirosine.
WJ0679 is a small-molecule oxytocin receptor agonist and vasopressin receptor antagonist. It acts specifically as a very weak partial agonist of the oxytocin receptor (Ki = 422 nM; EC50Tooltip half-maximal effective concentration = 406 nM; EmaxTooltip maximal efficacy = 13%) and as an antagonist of the vasopressin V1A receptor (Ki = 105 nM; IC50Tooltip half-maximal inhibitory concentration = 2,203 nM), whereas no data were reported for the vasopressin V2 receptor. Despite its low activational efficacy at the oxytocin receptor, WJ0679 induces prosocial effects, including increased time spent in close physical contact and increased active social investigation, in rodents. The chemical synthesis of WJ0679 has been described. Along with its close analogue CA7, WJ0679 has the smallest chemical structure known for an oxytocin receptor agonist, with WJ0679 having about 60% of the molecular weight of LIT-001 and both WJ0679 and CA7 lacking LIT-001's tail component. Many analogues of WJ0679 and CA7 have been described. WJ0679 was first described in the scientific literature by a group including Michael Kassiou, Michael Bowen, Iain McGregor, and others at the University of Sydney in 2018. This group has founded a startup pharmaceutical company called Kinoxis Therapeutics and is developing small-molecule oxytocin-related drugs like KNX-100 and the KNX-200 series for potential medical use as of the 2020s.
Laboratory studies indicate that BDNF may play a role in neurogenesis. BDNF can promote protective pathways and inhibit damaging pathways in the NSCs and NPCs that contribute to the brain's neurogenic response by enhancing cell survival. This becomes especially evident following suppression of TrkB activity. TrkB inhibition results in a 2–3 fold increase in cortical precursors displaying EGFP-positive condensed apoptotic nuclei and a 2–4 fold increase in cortical precursors that stained immunopositive for cleaved caspase-3. BDNF can also promote NSC and NPC proliferation through Akt activation and PTEN inactivation. Some studies suggest that BDNF may promote neuronal differentiation. Preliminary research has focused on the possible links between BDNF and depression.
Sources: en.wikipedia.org
In 1987, according to Department of State and congressional staff, drug traffickers were offering UMOPAR officers and town officials in the Chapare region amounts ranging from US$15,000 to US$25,000 for seventy two hours of "protection" in order to allow aircraft to load and take off from clandestine airstrips. In February 1988, the deputy minister of national defense announced that about 90 percent of UMOPAR members, including twelve middle- and high-ranking officers, had been dismissed for alleged links to drug trafficking. The La Paz newspaper Presencia reported in March 1988 that UMOPAR chiefs, including the prosecutors, were working with narcotics traffickers by returning to them the large drug finds and turning only the small ones in to the authorities. Observers considered UMOPAR forces in Santa Cruz to be more honest and dedicated. In October 1988, the undersecretary of the Social Defense Secretariat reiterated that drug traffickers had obtained the protection of important sectors of influence in Bolivia, including some military members and ordinary judges. He cited the example of Cochabamba's Seventh Division commander and four of his top officers, who were discharged dishonorably after they were found to be protecting a clandestine Chapare airstrip used by drug smugglers. The ministry official also announced that the navy was protecting drug-trafficking activities in the Puerto Villarroel area of the Chapare. For that reason, the United States suspended assistance to the navy temporarily in late 1988 until its commander was replaced.
=== Rites of passage and belonging === Traditionally, the most common reason for scarification has been as a rite of passage. Scarification has been widely used by many West African tribes to mark milestone stages in both men and women's lives, such as puberty and marriage. In many tribes, members unwilling to participate in scarification were generally not included in the group's activities, and are often shunned from their society. According to anthropologist Grace Harris, group members lacking the normal characteristics consistent with the group are not considered as having acquired the full standing as agents in their society; they would also lack the capacity for meaningful behavior, such as greeting, commanding, and stating. Therefore, scarification can transform partial tribe members into "normal" members entirely accepted by the group. Scarification is a form of language not readily expressed, except through extensive and intricate greetings, and gives the ability to communicate fully, which is a key element for being considered as a normal member of the group. One reason why scarification is used as confirmation of adulthood is how it shows the ability to endure pain. With young men, the endurance of the pain of scarring exhibits strength and discipline, especially in tribes where males have roles as hunters and warriors. A young man who has already experienced the feeling of torn or cut flesh is considered less likely to fear the teeth of a wild animal or the tip of an enemy's spear.
The WHO-convened Global Study of Origins of SARS-CoV-2 or the Joint WHO-China Study was a collaborative study between the World Health Organization and the Government of China on the origins of COVID-19. The study was commissioned by the Director-General of the World Health Organization following a request by the 2020 World Health Assembly in which 122 WHO members proposed a motion, which included a call for a "comprehensive, independent and impartial" study into the COVID-19 pandemic" The WHO disbanded the team and proposed a new panel called Scientific Advisory Group for Origins of Novel Pathogens.
=== Climate change and the environment === One of Trump's Executive Orders rescinded a Biden Order which rescinded a Trump order which withdrew the United States from the Paris Climate Accords. This chain of orders effectively was a re-leaving of the order, "Putting America First In International Environmental Agreements". The end result being that the United States is no longer a member. The order dissolved the following councils and offices by rescinding the Executive Order 14008 of January 27, 2021 (Tackling the Climate Crisis at Home and Abroad).
Sources: en.wikipedia.org
== Discovery == The parent structure of lefetamine, 1,2-diphenylethylamine was first synthesized in the 1940s and showed weak analgesic activity. Lefetamine itself was first investigated in Japan in the 1950s. The L-isomer showed weak analgesic action comparable to codeine and antitussive action far weaker than codeine. The d-isomer showed no such activity but caused seizures in rats.
A further derivative of rasagiline, ladostigil ([N-propargyl-(3R)-aminoindan-5-yl]-N-propylcarbamate), a dual MAO-B inhibitor and acetylcholinesterase inhibitor, was developed for treatment of Alzheimer's disease and other conditions but was ultimately never introduced for medical use.
Equality Consultancy was allegedly set up to cover up the bribes Antonio Panzeri would have received from foreign governments. Giorgi admitted according to the Financial Times helping Antonio Panzeri disguise money received from Morocco and Qatar. Among the clients of the Milan-based consultancy was the UK-based Turkish human rights consultant Hakan Camuz. Hakan Camuz said that he hired the firm for what he called ethical lobbying services, which included facilitating of meetings with members of the European Parliament. Hakan Camus' objective was to lobby for condemnation of war crimes in Syria and he declared having no knowledge of any wrongdoings of Giorgi and Antonio Panzeri. The commercial relationship started with Giorgi approaching him.
Sources: en.wikipedia.org
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.
No. The gastric protein is larger, while BPC-157 is a short fragment sequence. The peptide is produced synthetically for research use. The relationship is one of sequence origin, not chemical identity.
It is most often supplied as a lyophilized powder, frequently as the acetate salt. The powder is reconstituted with water or a buffer before use. Free-base and other salt forms also exist but are less common in catalogs.
The standard approach is reverse-phase high-performance liquid chromatography, reported as a percentage of total peak area. Because that figure alone says little about the nature of the impurities, the accompanying chromatogram is normally the more useful document for judging a batch.